HomeSAGE • NASDAQ
add
SAGE Therapeutics Inc
Previous close
$12.34
Day range
$11.86 - $12.46
Year range
$10.92 - $59.99
Market cap
716.17M USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 7.90M | 139.89% |
Operating expense | 52.57M | -19.99% |
Net income | -108.48M | 26.12% |
Net profit margin | -1.37K | 69.20% |
Earnings per share | -1.80 | 26.83% |
EBITDA | -117.34M | 24.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 717.01M | -36.52% |
Total assets | 767.60M | -37.12% |
Total liabilities | 61.80M | -29.42% |
Total equity | 705.80M | — |
Shares outstanding | 60.18M | — |
Price to book | 1.05 | — |
Return on assets | -35.66% | — |
Return on capital | -38.87% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -108.48M | 26.12% |
Cash from operations | -37.83M | 75.38% |
Cash from investing | 139.44M | -28.45% |
Cash from financing | 1.56M | -41.73% |
Net change in cash | 103.16M | 135.22% |
Free cash flow | -864.88K | 99.14% |
About
Founded
2010
Website
Employees
487